Coronary Collateral Circulation

The coronary collateral circulation provides alternative blood flow pathways when coronary arteries are occluded. Complete tutorial on collateral classification, development, and clinical significance.

This content is for informational purposes only. Always consult a healthcare professional.

Coronary collateral circulation is a network of interconnecting vessels that provides alternative blood flow to the myocardium when the primary coronary arteries are occluded or severely stenosed.

Definition and Overview

Coronary collaterals are pre-existing anastomotic connections between coronary artery territories that can enlarge and remodel in response to ischemia. They function as natural bypass channels that can limit infarct size and preserve myocardial function after coronary occlusion.

Classification of Collaterals

By Vessel Type

Arterioluminal:

  • Connect small coronary arteries directly to the cardiac chambers
  • Represent Thebesian veins connecting to the arterial system
  • Minimal functional significance

Arteriosinusoidal:

  • Connect arterioles to myocardial sinusoids
  • May provide limited collateral flow

Arterioarterial:

  • Direct connections between coronary arteries
  • Most clinically significant collateral type
  • Can enlarge to supply significant blood flow

By Size (Rentrop Classification)

Used during coronary angiography to grade collateral filling:

Grade Description
0 No visible collateral filling
1 Very faint collateral filling of side branches (not the epicardial vessel)
2 Partial filling of the epicardial vessel
3 Complete filling of the epicardial vessel

By Source

Homocollaterals: Connect branches of the same coronary artery (e.g., septal-to-septal within the LAD)

Heterocollaterals: Connect different coronary arteries (e.g., RCA to LAD via septal collaterals)

Major Collateral Pathways

Septal Collaterals (Most Important)

The septal perforating arteries form the most extensive collateral network.

Connections:

  • LAD septal perforators to PDA septal perforators
  • LAD septal perforators to posterior descending septal perforators

Advantages:

  • Protected by the septum from external compression
  • Short, direct connections
  • High capacity for flow

Epicardial Collaterals

Vieussens Ring: Anastomotic connection between the conus branch of the RCA and the LAD at the pulmonary infundibulum.

Other epicardial pathways:

  • LAD to diagonal to obtuse marginal (LCx territory)
  • Posterior LV branches of RCA to LCx marginal branches
  • Acute marginal (RCA) to distal LAD

Apical Collaterals

Connections at the cardiac apex between:

  • LAD and PDA (wrap-around LAD to PDA)
  • LAD and posterior LV branches

These are common but provide less flow than septal collaterals.

Atrial Collaterals

Connections between atrial branches:

  • Sinoatrial nodal artery to other atrial branches
  • Atrial branches to the AV nodal artery

Development of Collaterals

Preexisting Collaterals

Collateral vessels exist in the normal heart but are small (< 100 microns) and carry minimal flow:

  • Present from birth
  • Formed during embryonic development
  • Normally carry < 1% of total coronary blood flow

Arteriogenesis (Collateral Remodeling)

When a coronary artery becomes severely stenosed (> 70%), the pressure gradient across the collateral network drives flow.

Stages:

  1. Shear stress increase: Flow through preexisting collaterals increases
  2. Endothelial activation: Nitric oxide, adhesion molecule expression
  3. Monocyte recruitment: Macrophages clear debris, secrete growth factors
  4. Smooth muscle proliferation: Vascular wall remodeling
  5. Maturation: Collateral diameter increases up to 20-fold

Timeline:

  • Pressure gradient: Immediate
  • Increased flow: Hours to days
  • Visible collaterals on angiogram: 2-4 weeks
  • Mature collaterals: 1-3 months

Angiogenesis (New Vessel Formation)

In chronic ischemia, new capillary networks form through:

  • Hypoxia-inducible factor (HIF) activation
  • Vascular endothelial growth factor (VEGF) signaling
  • Endothelial cell proliferation and migration

Factors Affecting Collateral Development

Positive Factors

Factor Effect
Chronic ischemia Strongest stimulus for collateral development
Gradual coronary occlusion Allows time for collateral maturation
Exercise training Enhances collateral flow
Younger age Better collateral remodeling
Normal endothelial function Required for arteriogenesis
Nitric oxide Mediates flow-dependent remodeling

Negative Factors

Factor Effect
Diabetes mellitus Impaired collateral formation
Advanced age Reduced collateral response
Smoking Endothelial dysfunction impairs remodeling
Hyperlipidemia Reduces collateral flow
Hypertension Associated with poorer collaterals
Obesity Reduced collateral development
Female sex Conflicting evidence

Clinical Significance

Myocardial Protection

Infarct size reduction:

  • Well-developed collaterals can reduce infarct size by 30-50%
  • Preserve left ventricular function after coronary occlusion
  • Reduce mortality in acute myocardial infarction

Ischemic preconditioning:

  • Small ischemic episodes protect against subsequent larger ischemia
  • Collateral recruitment is one mechanism
  • Can be induced by angina before infarction

Angina Pectoris

Stable angina:

  • Patients with good collaterals may have less angina
  • Collaterals protect against exercise-induced ischemia
  • May allow longer survival in chronic total occlusion

Angina-to-MI ratio:

  • Patients with pre-infarction angina have better collaterals
  • Pre-infarction angina is associated with smaller infarcts

Chronic Total Occlusion (CTO)

Collaterals maintain myocardial viability in CTO:

  • 60-80% of CTO segments receive collateral flow
  • Myocardium remains viable for months to years
  • Successful recanalization improves regional function

Types of CTO Collaterals:

Collateral type Rentrop Grade Clinical Significance
Septal 2-3 Best for retrograde CTO crossing
Epicardial 2-3 Higher risk of perforation
Apical 1-2 Limited for retrograde access

Collaterals in Acute MI

Protective effects:

  • Smaller CK-MB peak
  • Better preserved LV function
  • Lower incidence of cardiogenic shock
  • Improved survival at 30 days and 1 year

Determinants of collateral protection:

  • Duration of occlusion (sudden vs. gradual)
  • Pre-existing collaterals (prior angina)
  • Territory at risk (proximal vs. distal occlusion)

Therapeutic Enhancement of Collaterals

Approaches under investigation:

  • Growth factor therapy: VEGF, FGF (limited clinical success)
  • Gene therapy: HIF-1 alpha, VEGF genes (experimental)
  • Cell therapy: Endothelial progenitor cells (investigational)
  • External counterpulsation: Enhanced external counterpulsation (EECP) improves collateral flow
  • Exercise training: Best-established non-pharmacologic approach

Imaging Collaterals

Modality Advantages Limitations
Coronary angiography Gold standard, interventional guidance Invasive, radiation
CT coronary angiography Noninvasive, anatomic detail Radiation, contrast
MRI Myocardial perfusion, viability Lower resolution for small collaterals
PET Quantitative flow assessment Radiation, limited availability
Doppler guidewire Physiologic assessment of collateral flow Invasive, limited to catheterization

Coronary Steal

Coronary steal occurs when pharmacologic vasodilation diverts flow away from collateral-dependent myocardium:

Mechanism:

  • Vasodilators (adenosine, dipyridamole) dilate resistance vessels
  • Normal arteries dilate more than collateral-dependent territories
  • Flow is redirected from the collateral-dependent region to the normal region
  • Can cause ischemia in collateral-dependent myocardium

Clinical relevance:

  • Important during pharmacologic stress testing
  • Contraindication to dipyridamole in patients with significant coronary disease
  • Adenosine stress perfusion imaging relies on this phenomenon